Periodic Reporting for period 1 - Cytodesign (Novel engineered cytokines for human therapy)

The direct use of recombinant bacteria, or indirectly using bacteriophages, producing and delivering in situ a therapeutic molecule of interest has been extensively described. Many such efforts have also shown high efficacy in animal models but have yet to yield clinical...